LIMRA: Workplace Supplemental Health Products and Disability Insurance Sales Increase in Third Quarter 2022
New annualized premium for supplemental health products - accident, critical illness, cancer, hospital indemnity, and other supplemental health insurance products/* - increased 3% in the third quarter 2022, according to LIMRA's workplace benefits sales surveys.
"Interest in critical illness coverage increased during the pandemic," said
In the third quarter of 2022,
New premiums sales for both group and individual workplace supplemental health products improved in the third quarter, up 2% and 5%, respectively. Through the first nine months of 2022, group and individual workplace supplemental health premiums also experienced growth. Group supplemental health product premium rose 12% while individual products increased 8%.
Total workplace disability insurance new premium sales were
Overall,
Life Insurance
In the third quarter, total workplace life insurance new premium was
For the quarter and for the first nine months of 2022, overall workplace life insurance premium declines were largely driven by a decrease in term life insurance premium, which fell 21% for the quarter and 5% for the first nine months of 2022.
"In 2021, we saw several large employer sales, which is hard to replicate year over year," Leary said. "We are, however, seeing more sales among small and midsize employers that held off making changes to their benefits during COVID."
LIMRA's workplace benefits sales surveys for life insurance, disability insurance and supplemental health represent at least 90% of their respective annualized premium markets.
You can find the latest data table with
Footnote:
*/"Other supplemental health products" represents products that do not fit the other categories, such as gap insurance, minimum essential coverage plans, limited benefit medical, and heart/stroke products.
* * *
Original text here: https://www.limra.com/en/newsroom/news-releases/2023/limra-workplace-supplemental-health-products-and-disability-insurance-sales-increase-in-third-quarter-2022/
Congressional Research Service Issues Insight White Paper on FY2023 NDAA – TRICARE for Reservists
AM Best Affirms Credit Ratings of MetLife, Inc. and Most of Its Life/Health Subsidiaries
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News